clinical trial · NCT05423717
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
InsomniaDaridorexant 10 mgDaridorexant 25 mgDaridorexant 50 mgPlacebo
brief summary
This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to \< 18 years with insomnia disorder.
started
Sep 6, 2022
primary completion
Jan 12, 2026
completion
Feb 5, 2026
last updated
Mar 6, 2026
official title
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography, Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Multiple-dose Oral Administration of Daridorexant in Pediatric Subjects Aged 10 to < 18 Years With Insomnia Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol